DOCSLIB.ORG

Endotoxins in Swine - Effects Structure

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Endotoxins in Swine - Effects Structure endotoxin toxicity. Also it is the toxins. conrmed in an in vivo test. more consistent portion of LPS A more practical approach to Table 2 shows free endotoxin Endotoxins in swine - effects structure. Currently, immunisation reduce binders. Toxin binders are concentration in blood of shows against lipid A is being developed, widely used to control other toxins before and after feeding them the but the high cost makes it a non-via- such mycotoxins. The binder and commercial toxin binder. and strategies for control ble option for livestock production. the mycotoxin form a complex that This preliminary data suggest than Another option considered in vacci- is too large to be absorbed into the the toxin binder is capable of biding By Josep Garcia-Sirera, Special Nutrients known. The O-polysaccharide nation is to immunise against LBP, in blood system. The complex is then endotoxin and the gastrointestinal Inc. 2766 Douglas Road, Miami, Fl 33133, portion seems to be relevant to an attempt to reduce the formation eliminated in the faeces. tract, and thus preventing endotox- USA. host-parasite interactions because of LBS-LBP complex that initiates Most mycotoxin binders are hydro- ins from being absorbed. its disappearance results in loss of the cascade of events leading to philic molecules (bentonites, alumi- Further studies are currently under- Endotoxins are structural compo- tibility to endotoxin and the mecha- cascade. Initial activation of Hage- pathogenesis. This option is also nosilicates) ecient at capturing way to further test this product. nents of bacteria. They are part of virulence. The loss of the proximal part of the nism is complex. man factor (blood-clotting Factor expensive and currently only to be polar molecules such as aatoxin. the outer membrane of Gram nega- In humans, LPS binds to a lipid bind- XII) can activate several humoral considered for human use. The capacity of These traditional Summary tive bacteria., which are released core oligosaccharide induces bacte- ing protein (LBP) in the serum which systems resulting in: • Immunity modulators. Use of mycotoxin binders to capture more Endotoxins have a wide variety of mainly when bacteria are lysed, due ria to become extremely sensitive to transfers it to CD 14 on the cell -Coagulation: a blood clotting immune modulators to compensate lipophilic-like molecules such zeara- eects on livestock aecting perfor- to the use of antibiotics or because detergents, antibiotics and bile Fig. 2 Schematic view of the cellular membrane, which in tum tein MD2, cascade that leads to coagulation, the eects of endotoxins have been lenone or DON is questionable. mance parameters. Dierent means of the body’s defence mechanism. salts. So it seems that this region is endotoxin (LPS) signal transduction which associates with toll-like thrombosis, which deplete platelets tested in animal production. In There are also organic mycotoxin targeting lipid A the toxin binder of control of endotoxins have been Together with phospholipids and essential for the maintenance of pathway . LPS bindind protein (LBP) receptor-4 (TLR4). and various clotting factors result- broilers, inoculation with LPS induc- binders (MOS based) that claim to would have a wider range of action. tested, but most of them are too membrane bound proteins they are outer membrane functions as a solved in the plasma ligates at LPS (I). This triggers the signaling cascade ing in internal bleeding. es an activation of the immune be able to absorb a wider range of Some preliminary studies have expensive to be considered in constituents pf the outer cell mem- biological barrier. Mutations altering the lipid A com- This complex binds to the cell surface for macrophage/endothelial cells to -Activation of the complement system. Some studies show that mycotoxins. already tested the posibility of using animal production. brane the typical structure of an receptor CDI4 (2). Aggregation of ponent are mostly not viable, secrete pro-inammatory cytokines alternative pathway (which leads to broilers inoculated with LPS When considering the possibility of toxin binders against endotoxins is A cost eective method would be endotoxin consists of a lypopolysac- LBP/LPS/CDI4 complex with the protein suggesting that it is important for and nitric oxide that lead to the inammation) decrease productivity. This reduc- using toxin binders to capture swine. Fig 3 the results of using a the use of toxin binders to capture charide (LPS). These LPS dene MD2 and the transmembrane toll like characteristic “endotoxic shock”. -Plasmin activation which leads to tion is related to the action of inter- endotoxins, the ideal binders candi- commercial available toxin binder endotoxins in the gastrointestinal many of the properties of host-para- the maintenance of outer mem- receptor (TLR) 4 (3) induces the signal CDI 4 and TLR4 are present on sever- brinolysis and haemorrhaging. leukins produced during the acute date should target lipid A. The to reduce free endotoxin concetra- tract and preventing them from site interactions. brane integrity as a whole. transduction cascade in the cell (4,5). al cells of the immunological -Kinin activation releases bradykinis inammatory phase. On the other reason being that lipid A is responsi- tion in endotoxin producing bacte- entering the blood systems. Some LPS consists of three structural Finally, transcription factor NFxB is Lipid A and virulence activated (6) and starts translation of system, including macrophages and and other vasoactive peptides hand, some studies show the ble for the pathogenic eects of rial cell culture. studies are underway to test this elements. One is a hydrophobic macrophages, three types of events which causes hypotension. immune-modulating action of endotoxins, and it is the portion of The product was capable of binding The physiological activities of LPS several genes to proteins, for example possibility. component, called lipid A, which are triggered during their interac- The nest eect is to induce inam- B-glucans present in yeast cell wall. the structure that remains constant endotoxins at two dierent inclu- are mediated mainly by the lipid A pro-inflammatory mediators like IL-IB serves to anchor the molecule into tion with LPS. mation, intravascular coagulation, Table I shows the results of using across dierent endotoxins, so by sion rates. This biding capacity was component of LPS. Lipid A is a pow- (7,8) the membrane. The second is a core •Production of cytokines including haemorrhage and shock. LPS also yeast cell wall (YCL) in diet of broil- erful biological response modier oligosaccharide. The third compo- IL-I, IL-6,IL-B tumour necrosis factor acts as a B cell mitogen, stimulating ers inoculated with LPS. YCL was that can stimulate the mammalian nent is a hydrophilic O-polysaccha- (TNF) and platelet activating factor. the polyclonal dierentiation and immune system. During infectious experimental animals causes a wide ride projecting into the extracellular These, in turn leukotrienes. These multiplication of B-cells and the disease caused by Gram negative spectrum of non-specic patho- space. More than 150 dierent are powerful mediators of inam- secretion of immunoglobulins, bacteria, endotoxins released from physiological reactions, such as variants of the third component are mation endotoxin toxaemia. LPS especially IgG and IgM. or part of multiplying cells have fever, changes in white blood cell activates macrophages to similar eects on animals and counts, disseminated intravascular enhanced phagocytosis and cyto- Fig. 1 Lypopolysaccharide structure signicantly contribute to the coagulation, hypotension, shock Control of endotoxins toxicity. Macrophages are stimu- symptoms and pathology of the and death. Injection of fairly small In general, strategies to control lated to produce and release lyso- disease encountered. doses of endotoxin results in death endotoxin contamination in somal enzymes. IL-1 (endopenous Since lipid A is embedded in the in most mammals. animals include all of those aimed at pyropen) and tumour necrosis outer membrane of bacterial cells, it The sequence of events follows a the reduction of bacterial contami- factor (TNFalpha), as well as other probably only exerts its toxic eects regular pattern: nation. These strategies include, but cytokines and mediators. when the bacteria are lysed as a •Latent period. are not limited to, biosecurity, use of •Activation of the complement result of autolysis and the mem- •Physiological distress (diarrhoes, prebiotics, probiotics and improved cascade. C3a and C5a cause hista- brane attack complex (MAC), inges- prostration, shock). nutrient digestibility. Other strate- mine realese (leading to vasodila- capable of counteracting the eects tion and killing by phagocytes, or •Death. gies such as vaccination and use of tion) and aects neutrophil chemo- of LPS in conversion index (CI). killing with certain types of antibiot- How soon death occurs varies on toxin binders specically target taxis and accumulation. The result is Further tests would be needed to ics. the doses of the endotoxin, route of endotoxin contamination. inammation. study the possibility of using The injection of living or killing Gran administration, and species of • Vaccination. As explained before, •Activation of the coagulation immune modulators against endo- negative cells or puried LPS into animal. Animals vary in their suscep- the lipid A portion is responsible for endotoxin toxicity. Also it is the toxins. conrmed in an in vivo test. more consistent portion of LPS A more practical approach to Table 2 shows free endotoxin structure. Currently, immunisation reduce binders. Toxin binders are concentration in blood of shows against lipid A is being developed, widely used to control other toxins before and after feeding them the but the high cost makes it a non-via- such mycotoxins. The binder and commercial toxin binder. ble option for livestock production. the mycotoxin form a complex that This preliminary data suggest than Another option considered in vacci- is too large to be absorbed into the the toxin binder is capable of biding By Josep Garcia-Sirera, Special Nutrients known.
Load more

Recommended publications
  • Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease
    toxins Review Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease Rosalia Marcano 1, M. Ángeles Rojo 2 , Damián Cordoba-Diaz 3 and Manuel Garrosa 1,* 1 Department of Cell Biology, Histology and Pharmacology, Faculty of Medicine and INCYL, University of Valladolid, 47005 Valladolid, Spain; [email protected] 2 Area of Experimental Sciences, Miguel de Cervantes European University, 47012 Valladolid, Spain; [email protected] 3 Area of Pharmaceutics and Food Technology, Faculty of Pharmacy, and IUFI, Complutense University of Madrid, 28040 Madrid, Spain; [email protected] * Correspondence: [email protected] Abstract: It is widely recognized that periodontal disease is an inflammatory entity of infectious origin, in which the immune activation of the host leads to the destruction of the supporting tissues of the tooth. Periodontal pathogenic bacteria like Porphyromonas gingivalis, that belongs to the complex net of oral microflora, exhibits a toxicogenic potential by releasing endotoxins, which are the lipopolysaccharide component (LPS) available in the outer cell wall of Gram-negative bacteria. Endotoxins are released into the tissues causing damage after the cell is lysed. There are three well-defined regions in the LPS: one of them, the lipid A, has a lipidic nature, and the other two, the Core and the O-antigen, have a glycosidic nature, all of them with independent and synergistic functions. Lipid A is the “bioactive center” of LPS, responsible for its toxicity, and shows great variability along bacteria. In general, endotoxins have specific receptors at the cells, causing a wide immunoinflammatory response by inducing the release of pro-inflammatory cytokines and the production of matrix metalloproteinases.
    [Show full text]
  • Instability of Toxin a Subunit of AB5 Toxins in the Bacterial Periplasm Caused by Deficiency of Their Cognate B Subunits
    Biochimica et Biophysica Acta 1808 (2011) 2359–2365 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbamem Instability of toxin A subunit of AB5 toxins in the bacterial periplasm caused by deficiency of their cognate B subunits Sang-Hyun Kim a, Su Hyang Ryu a, Sang-Ho Lee a, Yong-Hoon Lee a, Sang-Rae Lee a, Jae-Won Huh a, Sun-Uk Kim a, Ekyune Kim d, Sunghyun Kim b, Sangyong Jon b, Russell E. Bishop c,⁎, Kyu-Tae Chang a,⁎⁎ a The National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Chungbuk 363–883, Republic of Korea b School of Life Science, Gwangju Institute of Science and Technology (GIST), 1 Oryong-dong, Gwangju 500–712, Republic of Korea c Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada L8N 3Z5 d College of Pharmacy, Catholic University of Daegu, Hayang-eup, Gyeongsan, Gyeongbuk 712-702, Republic of Korea article info abstract Article history: Shiga toxin (STx) belongs to the AB5 toxin family and is transiently localized in the periplasm before secretion Received 26 April 2011 into the extracellular milieu. While producing outer membrane vesicles (OMVs) containing only A subunit of Received in revised form 3 June 2011 the toxin (STxA), we created specific STx1B- and STx2B-deficient mutants of E. coli O157:H7. Surprisingly, Accepted 23 June 2011 STxA subunit was absent in the OMVs and periplasm of the STxB-deficient mutants. In parallel, the A subunit Available online 5 July 2011 of heat-labile toxin (LT) of enterotoxigenic E.
    [Show full text]
  • Mycotoxin Analysis in Infant Formula Using Captiva EMR-Lipid
    Application Note Food Testing & Agriculture Mycotoxin Analysis in Infant Formula Using Captiva EMR—Lipid Cleanup and LC/MS/MS Author Abstract Derick Lucas Agilent Technologies, Inc. Several countries regulate the levels of mycotoxins in foods. However, the complexity of certain foodstuffs in terms of protein and lipid content can prove challenging in the accurate quantitation of low-level mycotoxins in these matrices. This Application Note describes the determination of 13 multiclass mycotoxins in solid and liquid infant formulations using a Quick Easy Cheap Effective Rugged Safe (QuEChERS) workflow followed by Agilent Captiva EMR—Lipid cartridge cleanup. Due to the high selectivity of the Captiva EMR—Lipid sorbent, excellent recoveries (70.4 to 106.8 %) and precision (<18 %) were achieved for all mycotoxins. This simple and robust methodology requires minimal equipment and expertise, which promotes easy implementation in food laboratories. Introduction Experimental Mycotoxins are produced as secondary metabolites by fungal Sample preparation species that grow on various crops such as grain, corn, and • Captiva EMR—Lipid 3-mL tubes (p/n 5190-1003) nuts. When cows ingest contaminated feed, mycotoxins and their metabolites can be excreted into the animal’s milk1. • Captiva EMR—Lipid 6-mL tubes (p/n 5190-1004) Aflatoxin M1 is the most commonly found mycotoxin in milk, • QuEChERS original extraction salts (p/n 5982-5550) and is monitored and regulated in many countries, including • VacElut SPS 24 vacuum manifold (p/n 12234022) the United States and European countries2,3. Despite a lack of regulations for other mycotoxins in milk, there is a growing LC configuration and parameters interest to monitor additional mycotoxins such as fumonisins and ochratoxins.
    [Show full text]
  • Impact of Bacterial Toxins in the Lungs
    toxins Review Impact of Bacterial Toxins in the Lungs 1,2,3, , 4,5, 3 2 Rudolf Lucas * y, Yalda Hadizamani y, Joyce Gonzales , Boris Gorshkov , Thomas Bodmer 6, Yves Berthiaume 7, Ueli Moehrlen 8, Hartmut Lode 9, Hanno Huwer 10, Martina Hudel 11, Mobarak Abu Mraheil 11, Haroldo Alfredo Flores Toque 1,2, 11 4,5,12,13, , Trinad Chakraborty and Jürg Hamacher * y 1 Pharmacology and Toxicology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; hfl[email protected] 2 Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; [email protected] 3 Department of Medicine and Division of Pulmonary Critical Care Medicine, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA; [email protected] 4 Lungen-und Atmungsstiftung, Bern, 3012 Bern, Switzerland; [email protected] 5 Pneumology, Clinic for General Internal Medicine, Lindenhofspital Bern, 3012 Bern, Switzerland 6 Labormedizinisches Zentrum Dr. Risch, Waldeggstr. 37 CH-3097 Liebefeld, Switzerland; [email protected] 7 Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada; [email protected] 8 Pediatric Surgery, University Children’s Hospital, Zürich, Steinwiesstrasse 75, CH-8032 Zürch, Switzerland; [email protected] 9 Insitut für klinische Pharmakologie, Charité, Universitätsklinikum Berlin, Reichsstrasse 2, D-14052 Berlin, Germany; [email protected] 10 Department of Cardiothoracic Surgery, Voelklingen Heart Center, 66333
    [Show full text]
  • Host-Based Lipid Inflammation Drives Pathogenesis in Francisella Infection
    Host-based lipid inflammation drives pathogenesis in Francisella infection Alison J. Scotta, Julia Maria Postb, Raissa Lernerb, Shane R. Ellisc, Joshua Liebermand, Kari Ann Shireye, Ron M. A. Heerenc, Laura Bindilab, and Robert K. Ernsta,1 aDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD 21201; bLaboratory for Eicosanoids and Endocannabinoids, Johannes Gutenberg University Mainz, 55099 Mainz, Germany; cMaastricht MultiModal Molecular Imaging Institute, Maastricht University, 6229 ER Maastricht, The Netherlands; dDepartment of Pathology, University of Washington Medical Center, Seattle, WA 98118; and eDepartment of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD 21201 Edited by Roy Curtiss III, University of Florida, Gainesville, FL, and approved October 16, 2017 (received for review July 19, 2017) Mass spectrometry imaging (MSI) was used to elucidate host lipids MSI (18), although other ionization methods [such as desorption involved in the inflammatory signaling pathway generated at the electrospray ionization (DESI) and liquid extraction surface host–pathogen interface during a septic bacterial infection. Using analysis (LESA), and others] are also employed. MSI has been Francisella novicida as a model organism, a bacterial lipid virulence used in a wide array of applications ranging from fingerprint factor (endotoxin) was imaged and identified along with host phos- analysis to mapping drug distribution in tissue. MSI studies of pholipids involved in the splenic response in murine tissues. Here, cancer biology for biomarker discovery, therapeutic target iden- we demonstrate detection and distribution of endotoxin in a lethal tification, and fundamental pathology hold particular promise. In murine F. novicida infection model, in addition to determining the contrast, comparatively few systematic studies have leveraged MSI – temporally and spatially resolved innate lipid inflammatory response to describe the host microbe relationship (19, 20).
    [Show full text]
  • Determination of Lipid a and Endotoxin in Serum by Mass Spectroscopy (Ft-Hydroxymyristic Acid/Gas Chromatography-Mass Spectrometry/Gram-Negative Sepsis) SHYAMAL K
    Proc. Nati. Acad. Sci. USA Vol. 75, No. 8, pp. 3993-3997, August 1978 Medical Sciences Determination of lipid A and endotoxin in serum by mass spectroscopy (ft-hydroxymyristic acid/gas chromatography-mass spectrometry/Gram-negative sepsis) SHYAMAL K. MAITRA*t, MICHAEL C. SCHOTZtf, THOMAS T. YOSHIKAWA*t, AND LUCIEN B. GUZE*tl * Research Service, Veterans Administration, Wadsworth Hospital Center, Los Angeles, California 90073; * Departments of Medicine, Harbor General Hospital, Torrance, California 90509; and t UCLA School of Medicine, Los Angeles, California 90024 Communicated by William N. Valentine, June 1, 1978 ABSTRACr A quantitative technique for determining lipid tography-mass spectrometry. Mass spectrometry has been used A content of endotoxin added to serum by combined gas chro- successfully in the past to detect various biological compounds matography-mass spectrometry is described. This technique uses (26). This procedure is highly specific and very sensitive. detection of the -hydroxymyristic acid content of Salmonella The minnesota R595 lipopolysaccharide by selected ion monitoring method described in this communication quantitates nanogram at atomic mass unit of 315.4 The fatty acids produced on hy- quantities of lipid A and endotoxin in serum. drolysis of serum containing lipopolysaccharide were extracted and the methyl esters were made. Silica gel chromatography was MATERIALS AND METHODS used to separate methyl esters of hydroxy fatty acids from other Serum Samples. New Zealand white rabbits weighing ap- fatty acid methyl esters. Trimethylsilyl ether derivatives of the proximately 2 kg, and not fed overnight, were used. Blood was hydroxy fatty acid methyl ester fraction were quantitated by this technique. As little as 200 fmol of fi-hydroxymyristic acid obtained by heart puncture under sterile conditions.
    [Show full text]
  • LIPID MEDIATORS in HEALTH and DISEASE II: from the Cutting Edge–A Tribute to Edward Dennis and 7TH INTERNATIONAL CONFERENCE on PHOSPHOLIPASE A2 and LIPID MEDIATORS
    LIPID MEDIATORS IN HEALTH AND DISEASE II: From The Cutting Edge–A Tribute to Edward Dennis And 7TH INTERNATIONAL CONFERENCE ON PHOSPHOLIPASE A2 and LIPID MEDIATORS: From Bench To Translational Medicine Honorary Chair: Nobel Laureate Bengt Samuelsson La Jolla, California May 19-20, 2016 http://www.medschool.lsuhsc.edu/neuroscience/LipidMediatorsPLA2-2016/ Lipid Mediators in Health and Disease II: From The Cutting Edge • A Tribute to Edward Dennis 2+ Steered molecular dynamics simulation of Group VIA Ca - independent phospholipase A2 (PLA2) embedded in a bilayer membrane composed mainly of 1-palmitoyl, 2-oleoyl phosphatidycholine (POPC) extracting and pulling a 1-palmitoyl, 2-archidonyl phosphatidylcholine (PAPC) into its binding pocket in the active site. [For movies of this simulation, see Mouchlis VD, Bucher, D, McCammon, JA, Dennia EA (2015) Membranes serve as allosteric activators of phospholipase A2 enabling it to extract, bind, and hydrolyze phospholipid substrates, Proc Natl Acad Sci U S A, 112, E516-25.] Lipid Mediators in Health and Disease II: From The Cutting Edge • A Tribute to Edward Dennis WELCOME I would like to welcome all of the participants of the Lipid Mediators in Health and Disease II: From The Cutting Edge, A Tribute to Edward Dennis, and the 7th International Conference on Phospholipase A2 and Lipid Mediators: From Bench To Translational Medicine. This conference follows upon the very successful meeting led by Professor Jesper Z. Haeggström at the Karolinska Institutet, Nobel Forum, Stockholm, Sweden, on August 27-29, 2014, where Nobel Laureate Professor Bengt Samuelsson was honored. Lipids serve a myriad of essential functions in cell signaling, cell organization, energy metabolism, and overall homeostasis.
    [Show full text]
  • Clostridium Perfringens
    INFECTION AND IMMUNITY, Aug. 1997, p. 3485–3488 Vol. 65, No. 8 0019-9567/97/$04.0010 Copyright © 1997, American Society for Microbiology Clostridium perfringens Enterotoxin Lacks Superantigenic Activity but Induces an Interleukin-6 Response from Human Peripheral Blood Mononuclear Cells TERESA KRAKAUER,1 BERNHARD FLEISCHER,2 DENNIS L. STEVENS,3,4 5 1 BRUCE A. MCCLANE, AND BRADLEY G. STILES * Department of Immunology and Molecular Biology, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, Maryland1; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany2; Infectious Diseases Section, Veterans Administration Medical Center, Boise, Idaho3; University of Washington School of Medicine, Seattle, Washington4; and Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania5 Received 20 February 1997/Returned for modification 3 April 1997/Accepted 22 May 1997 We investigated the potential superantigenic properties of Clostridium perfringens enterotoxin (CPE) on human peripheral blood mononuclear cells (PBMC). In contrast to the findings of a previous report (P. Bowness, P. A. H. Moss, H. Tranter, J. I. Bell, and A. J. McMichael, J. Exp. Med. 176:893–896, 1992), two different, biologically active preparations of CPE had no mitogenic effects on PBMC. Furthermore, PBMC incubated with various concentrations of CPE did not elicit interleukin-1, interleukin-2, gamma interferon, or tumor necrosis factor alpha or beta, which are cytokines commonly associated with superantigenic stimulation. However, CPE did cause a dose-related release of interleukin-6 from PBMC cultures. Clostridium perfringens enterotoxin (CPE) is traditionally Additionally, the full-length recombinant CPE species used in recognized as a virulence factor responsible for the diarrheal this study has recently been characterized in detail (10) and and cramping symptoms associated with C.
    [Show full text]
  • Scientific Program
    Scientific Program 1 he Annual Meeting of the Brazilian Biophysics Society, one of the largest T and most traditional gathering of Biophysicists in Latin America, occurs during the second semester of each year. Now in its 43rd edition, the 2018 meeting will be held again at the Mendes Plaza Hotel, in the city of Santos (SP), from September 27th to 30th. A rich program of 16 symposia, 4 plenary talks, and 2 poster sessions covering a broad range of topics in Biophysics will guarantee the appropriate environment for productive discussions about developments regarding Biophysics and its interfaces with Biochemistry, Medicine, Pharmacy, among other disciplines. World leaders in several areas of Biophysics, from at least 12 different countries have already confirmed participation in our meeting this year! We will host researchers from Argentina, Belgium, Canada, Denmark, England, France, Germany, Israel, Portugal, United States, Uruguay and, of course, from Brazil, which will be represented by colleagues from 10 different states. This shows our broad representation in both national and international scenarios. We believe our meeting is the perfect opportunity for researchers interested in Biophysics and related fields to present their latest results to a very distinguished audience. Therefore, we invite you to participate and to submit an abstract for the poster sessions. Looking forward to seeing you in Santos! Antonio Costa-Filho President of SBBf 2 3 Index Iseli L. Nantes Cardoso ................................................ 56 Tayana Mazin Tsubone ................................................. 83 Juliana S Yoneda ........................................................ 57 Yan M. H. Gonçalves ................................................... 84 Organizing Committee ............................................7 Katia Regina Perez ....................................................... 33 Lucas Rodrigues de Mello............................................ 57 Yeny Y. P. Valencia ....................................................
    [Show full text]
  • Universidade De São Paulo Escola De Comunicações E Artes Departamento De Informação E Cultura
    UNIVERSIDADE DE SÃO PAULO ESCOLA DE COMUNICAÇÕES E ARTES DEPARTAMENTO DE INFORMAÇÃO E CULTURA Bruna Acylina Gallo Indicadores de Produção Científica: o caso do Instituto Butantan São Paulo 2019 Bruna Acylina Gallo Indicadores de Produção Científica: o caso do Instituto Butantan Relatório Final de Iniciação Científica submetido ao Departamento de Informação e Cultura da Escola de Comunicações e Artes da Universidade de São Paulo. Orientador: Profª. Drª. Nair Yumiko Kobashi São Paulo 2019 AGRADECIMENTOS Gostaria de agradecer à minha orientadora, professora Nair Yumiko Kobashi por orientar este trabalho e por tantos aprendizados. E à Mariana Crivelente por me auxiliar nessa caminhada, pela paciência e colaboração, pois o trabalho analisou parte dos dados do projeto de sua dissertação “Métodos e técnicas bibliométricas de análise de produção científica: um estudo crítico”, do Programa de Pós- Graduação em Ciência da Informação da Escola de Comunicações e Artes. RESUMO Análise de produção científica do Instituto Butantan, do período 2007-2016, recuperados na Plataforma Lattes. O objetivo da pesquisa foi compreender os conceitos e métodos da Bibliometria e realizar um estudo de caso para aplicá-los. O trabalho seguiu os seguintes procedimentos: revisão de literatura; recuperação de artigos de pesquisadores do Instituto Butantan registrados na Plataforma Lattes; limpeza e normalização dos dados; tratamento bibliométrico dos dados; comparação dos resultados com os indicadores de produção científica publicados nos relatórios anuais do Instituto Butantan. Os resultados referem-se aos seguintes aspectos: indicadores de produção científica e de outras atividades de pesquisa e discussão dos problemas encontrados na produção de indicadores. O processo de pesquisa foi importante para conhecer os conceitos e métodos da Bibliometria e trazer à luz os diversos problemas enfrentados em estudos bibliométricos.
    [Show full text]
  • Perspectives
    PERSPECTIVES not undergone decomposition failed to have TIMELINE such effects. In attempts to isolate and charac- terize the poisonous material, Peter L. Panum (1820–1885) could be considered a pioneer. Innate immune sensing and its roots: He showed that putrid fluids contained a water-soluble, but alcohol-insoluble, heat- the story of endotoxin resistant, non-volatile substance, which was lethal to dogs3. Also, Ernst von Bergmann (1836–1906) believed that a chemically Bruce Beutler and Ernst Th. Rietschel defined substance was responsible for putrid intoxication, which he termed sepsin4. How does the host sense pathogens? formed the conceptual framework within Of course, the contagionists could not Our present concepts grew directly which early workers sought to identify it. explain how a single contact with putrid flu- from longstanding efforts to understand Impressed by the malodorous exhalations ids or a sick patient could transmit so much infectious disease: how microbes harm of patients suffering from plague and their poison that not only the affected person, but the host, what molecules are sensed and, similarity to the foul vapours emanating from also thousands of other people, would die. It ultimately, the nature of the receptors that marshes, physicians came to believe that the was, therefore, an intellectual breakthrough the host uses. The discovery of the host putative poison was generated by putrefac- to postulate that the putrid venom commu- sensors — the Toll-like receptors — was tion (from the Greek for sepsis) of organic nicated by miasma or contagion could rooted in chemical, biological and genetic matter present in sick people or in locations reproduce in the affected individual, thereby analyses that centred on a bacterial poison, such as swamps.
    [Show full text]
  • Molecular Aspects of Endotoxic Reactions A
    BACTERIOLCGICAL REVIEWS, Mar. 1969, p. 72-98 Vol. 33, No. I Copyright © 1969 American Society for Microbiology Printed in U.S.A. Molecular Aspects of Endotoxic Reactions A. NOWOTNY Department of Microbiology, Temple University School of Medicine, Philadelphia, Pennsylvania 19122 INTRODUCTION............................................................ 72 CHEMICAL PROPERTIES AND CONSTITUENTS ............................ 73 BIOLOGICAL PROPERTIES ................................................. 73 Characteristic Endotoxic Reactions ............................................ 73 Sensitization and Desensitization Against Endotoxic Effects ....................... 75 Relationships Among Endotoxic Reactions ...................................... 76 Fate of Injected Endotoxins ................................................... 77 RELATION OF STRUCTURAL PARTS TO BIOLOGICAL FUNCTIONS ........ 78 Role of Polysaccharides ..................................................... 78 Role of Polypeptides ........................................................ 78 Lipid Moiety ........................................................... 78 Polysaccharide-free Endotoxic Glycolipids ....... ............................... 80 SEARCH FOR THE TOXIC PRINCIPLE ..................................... 80 Role of Hypersensitivity ..................................................... 80 Relation of Particle Size to Endotoxicity ....................................... 81 Toxic Constituents or Toxic Conformation? ..................................... 82 DETOXIFICATION AS
    [Show full text]